Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;46(6):782-788.
doi: 10.1097/MPA.0000000000000847.

Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic Specimens

Affiliations

Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic Specimens

Moh'd Khushman et al. Pancreas. 2017 Jul.

Abstract

Objectives: Exosomes are important mediators in intercellular communications and play a role in cancer progression and metastasis. Exosomal membranes are enriched in endosome-specific tetraspanins (CD9 and CD63). Here, we explored the expression of CD63 and CD9 utilizing immunohistochemistry in malignant and nonmalignant cells in 29 resected pancreatic specimens (RPSs) of mixed racial background.

Methods: The pathologic tissues (PTs) and adjacent normal tissues (ANTs) in each RPS were stained for CD63 and CD9. Two pathologists independently scored the expression of CD63 and CD9. Staining intensity was graded from 1 to 3. Staining percentage was estimated in 10% increments. An average Quick score (Q score) (intensity × percentage of staining) was calculated. Unpaired t test was used for statistical analysis.

Results: The mean multiplicative Q score for CD63 and CD9 expression is higher in PTs (209 and 72) compared with ANTs (154 and 24) (P = 0.0041, P = 0.0018), respectively. The Mean Q score for CD63 and CD9 expression is higher in the malignant PTs (231 and 85) compared with ANTs (129 and 25) (P < 0.0001 and P < 0.0124).

Conclusions: Exosomal markers (CD63 and CD9) expression assessment using immunohistochemistry is feasible in RPS. The expression of CD63 and CD9 is higher in PTs and malignant PTs compared with their ANTs.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors of this manuscript have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
H&E staining and CD63 and CD9 expression in malignant pathologic tissues (PTs) and their adjacent normal tissues (ANTs). (200X)
Figure 2
Figure 2
H&E staining and CD63 and CD9 expression in premalignant pathologic tissues and their adjacent normal tissues (ANTs). (200X)
Figure 3
Figure 3
H&E staining and CD63 and CD9 expression in inflammatory pathologic tissues and their adjacent normal tissues (ANTs). 200X
Figure 4
Figure 4
Exosomal markers CD9 and CD63 expression pattern in resected pancreatic tissues. Pathologic Tissues (PTs); Adjacent Normal Tissues (ANTs); Malignant PTs (MPTs); Malignant ANTs (MANTs); Premalignant PTs (PPTs); Premalignant ANTs (PANTs); Inflammatory PTs (IPTs); Inflammatory ANTs (IANTs); ***P <0.001; **P <0.01; *P <0.05.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. - PubMed
    1. Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010;7:163–172. - PubMed
    1. Lotvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913. - PMC - PubMed
    1. Mathivanan S, Fahner CJ, Reid GE, et al. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012;40:D1241–D1244. - PMC - PubMed
    1. Demory BM, Higginbotham JN, Franklin JL, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics. 2013;12:343–355. - PMC - PubMed